loader 1
20+% of breast conserving surgeries require re-excision. We want to make that 0%
To achieve clear margins, surgeons may remove more of the healthy breast tissue at the edges than is absolutely necessary – this approach may affect breast cosmetic outcomes post-operation.
A pre-operative breast MRI is typically taken in a prone position but the surgery takes place in a supine position, therefore, the prone MRI images are not very helpful.
Today’s tumor localization and tissue inspection technologies are unable to provide a complete and precise picture of the location, size, shape, depth, and edges of the tumor in the supine position to effectively aid surgeons with removing the entire tumor.
The leading approach, wire or seed localization, requires an invasive, inconvenient, and even painful pre-surgical procedure, inserting a wire or a seed to locate and mark the tumor. Localization results in 20-25% re-excision rates.
The Breast Cancer Locator™ System (BCL™) is a proprietary, patient-specific, 3D-printed surgical guidance system designed to achieve clear margins.
Every breast cancer tumor is unique. The tumor location, size, shape, depth and edges are difficult to identify with precision during surgery. Our BCL™ is designed to overcome these challenges.
The Visualizer™ provides an interactive 3D view of the area surrounding the tumor of the patient in the supine position –
the same position the patient is in on the Operating Room table.
For the first time, surgeons are using 3D visualization to localize and direct total breast cancer tumor removal.
Use the right mouse button to rotate and the mouse scroll wheel to zoom. Experience is optimized for Chrome and Firefox browsers.
It has been said that “simplicity” is the ultimate sophistication. To deliver an elegant solution requires complex analysis to understand the underlying challenges. In essence, it takes a lot of effort to make something simple.
The BCL™ System significantly reduces or eliminates guesswork regarding tumor size, shape, and location by providing a blueprint of the tumor and a surgical guide, thereby increasing precision in breast cancer surgery.
Learn More
LEBANON, N.H., September 19, 2024--(BUSINESS WIRE)--Cairn Surgical, Inc., an innovative medical technology firm striving to make breast cancer surgery more...
[Business Wire link] September 04, 2024 08:00 AM Eastern Daylight Time LEBANON, N.H.--(BUSINESS WIRE)--Cairn Surgical, Inc., an innovative medical technology...
Funds to Support Pivotal Trial Completion and Early Commercialization LEBANON, NH – August 21, 2024 — Cairn Surgical, Inc., an...
System Designed to Reduce the Incidence of Positive Margins – or Cancer Left Behind - After Breast Cancer Surgery
The Breast Cancer Locator™ from Cairn Surgical has been named the 2021 Product of the Year by the NH Tech...
CairnSurgical: Patient-Specific, Real-Time Guidance for Breast Cancer Surgery
Clinical Study to Evaluate System’s Ability to Reduce Positive Margin Rate. The first patient has been treated in the pivotal...
Celdara Medical, LLC today announced that the first DRIVEN Accelerator Hub Participant Company, CairnSurgical, Inc., has closed a Series A...
